CPA Global has found that Sanofi files the most patents covering human gene therapy and also spends the most on them overall.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Sanofi, CPA Global, gene patents, gene therapy, uniQure, CRISPR